Lucy Day
Financieel Directeur/CFO bij AN2 THERAPEUTICS, INC.
Vermogen: 60 948 $ op 31-05-2024
Actieve functies van Lucy Day
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AN2 THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-11-2019 | - |
Loopbaan van Lucy Day
Eerdere bekende functies van Lucy Day
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANACOR PHARMACEUTICALS INC | Financieel Directeur/CFO | 01-03-2002 | 01-08-2016 |
| Human Resources Officer | 01-03-2002 | 01-08-2016 | |
| Centaur Pharmaceuticals, Inc. | Financieel Directeur/CFO | 01-02-1994 | 01-01-2002 |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Corporate Officer/Principal | 01-01-1990 | 01-01-1994 |
Opleiding van Lucy Day
| University of California, Berkeley | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Director of Finance/CFO | 3 |
| Human Resources Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AN2 THERAPEUTICS, INC. | Health Technology |
| MERRILL LYNCH PREFERRED CAPITAL TRUST I | Finance |
| Bedrijven in privébezit | 2 |
|---|---|
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Centaur Pharmaceuticals, Inc. | Health Technology |
